1. Home
  2. CHT vs RMD Comparison

CHT vs RMD Comparison

Compare CHT & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chunghwa Telecom Co. Ltd.

CHT

Chunghwa Telecom Co. Ltd.

SELL

Current Price

$43.14

Market Cap

33.9B

ML Signal

SELL

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$214.06

Market Cap

32.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHT
RMD
Founded
1996
1989
Country
Taiwan
United States
Employees
N/A
10600
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.9B
32.2B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
CHT
RMD
Price
$43.14
$214.06
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$292.56
AVG Volume (30 Days)
121.2K
899.5K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
3.02%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.37
$10.60
Revenue Next Year
$3.23
$7.41
P/E Ratio
$26.66
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$39.28
$212.22
52 Week High
$47.03
$293.81

Technical Indicators

Market Signals
Indicator
CHT
RMD
Relative Strength Index (RSI) 54.27 33.32
Support Level $41.94 N/A
Resistance Level $43.91 $260.21
Average True Range (ATR) 0.53 5.03
MACD 0.03 -0.66
Stochastic Oscillator 61.92 14.69

Price Performance

Historical Comparison
CHT
RMD

About CHT Chunghwa Telecom Co. Ltd.

Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company's reportable segments are: Consumer Business, Enterprise Business, International Business, and Others. The majority of its revenue comes from the Consumer Business, which focuses on individual and home-centric businesses, such as mobile, fixed broadband, Wi-Fi, IPTV (MOD), and OTT services. The Enterprise business offers IDC, cloud, cybersecurity, 5G, AIoT, data, AI, enterprise digital transformation, and system integration services to businesses, and the International business segment represents services offered to international customers. Geographically, the company generates maximum revenue from its business in Taiwan.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: